chr4-147875047-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_024605.4(ARHGAP10):c.729G>A(p.Arg243=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00325 in 1,604,706 control chromosomes in the GnomAD database, including 109 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 34 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 75 hom. )
Consequence
ARHGAP10
NM_024605.4 synonymous
NM_024605.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.831
Genes affected
ARHGAP10 (HGNC:26099): (Rho GTPase activating protein 10) Predicted to enable GTPase activator activity. Predicted to be involved in cytoskeleton organization and negative regulation of apoptotic process. Predicted to be located in perinuclear region of cytoplasm and plasma membrane. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 4-147875047-G-A is Benign according to our data. Variant chr4-147875047-G-A is described in ClinVar as [Benign]. Clinvar id is 717842.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.831 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0127 (1940/152242) while in subpopulation AFR AF= 0.0422 (1753/41524). AF 95% confidence interval is 0.0406. There are 34 homozygotes in gnomad4. There are 913 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 34 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP10 | NM_024605.4 | c.729G>A | p.Arg243= | synonymous_variant | 8/23 | ENST00000336498.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP10 | ENST00000336498.8 | c.729G>A | p.Arg243= | synonymous_variant | 8/23 | 1 | NM_024605.4 | P1 | |
ARHGAP10 | ENST00000506054.5 | n.5861G>A | non_coding_transcript_exon_variant | 2/17 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0127 AC: 1930AN: 152124Hom.: 34 Cov.: 33
GnomAD3 genomes
AF:
AC:
1930
AN:
152124
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00487 AC: 1185AN: 243136Hom.: 19 AF XY: 0.00438 AC XY: 576AN XY: 131582
GnomAD3 exomes
AF:
AC:
1185
AN:
243136
Hom.:
AF XY:
AC XY:
576
AN XY:
131582
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00225 AC: 3272AN: 1452464Hom.: 75 Cov.: 30 AF XY: 0.00235 AC XY: 1697AN XY: 722466
GnomAD4 exome
AF:
AC:
3272
AN:
1452464
Hom.:
Cov.:
30
AF XY:
AC XY:
1697
AN XY:
722466
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0127 AC: 1940AN: 152242Hom.: 34 Cov.: 33 AF XY: 0.0123 AC XY: 913AN XY: 74424
GnomAD4 genome
AF:
AC:
1940
AN:
152242
Hom.:
Cov.:
33
AF XY:
AC XY:
913
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
32
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at